Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway

Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells via ERK/JNK Pathway

BackgroundSuppression of tumorigenicity 5 (ST5) has been considered as a tumor suppressor gene in HeLa tumor cells. However, its role in the progression of breast cancer remains vague.MethodsOnline database analysis was determined by Oncomine and Breast Cancer Gene-Expression Miner v4.4 (bc-GenExMin...

Full description

Bibliographic Details
Main Authors:	Jianghong Cheng, Mingli Li, Chi-Meng Tzeng, Xingchun Gou, Shuai Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Oncology
Subjects:	suppression of tumorigenicity 5 ERK1/2 JNK methylation breast cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.621500/full

Similar Items

Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
by: Hasan A, et al.
Published: (2020-08-01)

Roles of oxidative stress/JNK/ERK signals in paraquat-triggered hepatic apoptosis
by: Kuan-I Lee, et al.
Published: (2024-01-01)

C-Src Is Activated by the EGF Receptor in a Pathway that Mediates JNK and ERK Activation by Gonadotropin-Releasing Hormone in COS7 Cells
by: Sarah Kraus, et al.
Published: (2020-11-01)

Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
by: Zeyu Zhang, et al.
Published: (2024-04-01)

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure
by: Dong-Hui Huang, et al.
Published: (2016-01-01)

JNK Mediates Differentiation, Cell Polarity and Apoptosis During Amphioxus Development by Regulating Actin Cytoskeleton Dynamics and ERK Signalling
by: Ildiko M. L. Somorjai, et al.
Published: (2021-10-01)

The Hypothetical Inclusion Membrane Protein CPSIT_0846 Regulates Mitochondrial-Mediated Host Cell Apoptosis via the ERK/JNK Signaling Pathway
by: Ting Tang, et al.
Published: (2021-02-01)

Predictive value of soluble suppression of tumorigenicity 2 in atrial fibrillation: a systematic review and meta-analysis
by: Pengfei Chen, et al.
Published: (2024-01-01)

JNK, p38, ERK, and SGK1 Inhibitors in Cancer
by: Jonas Cicenas, et al.
Published: (2017-12-01)

Soluble suppression of tumorigenicity 2 associated with atrial fibrillation detected after stroke: A retrospective study
by: Wenquan Hou, et al.
Published: (2023-11-01)

Stimulation of JNK Phosphorylation by the PTTH in Prothoracic Glands of the Silkworm, Bombyx mori
by: Shi-Hong Gu, et al.
Published: (2018-02-01)

Methylsulfonylmethane ameliorates inflammation via NF-κB and ERK/JNK-MAPK signaling pathway in chicken trachea and HD11 cells during Mycoplasma gallisepticum infection
by: Yusong Miao, et al.
Published: (2022-04-01)

The antagonistic effect of selenium on lead-induced apoptosis and necroptosis via P38/JNK/ERK pathway in chicken kidney
by: Zhiruo Miao, et al.
Published: (2022-02-01)

Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States
by: Hasan A, et al.
Published: (2020-10-01)

Incorporation of Suppression of Tumorigenicity 2 into Random Survival Forests for Enhancing Prediction of Short-Term Prognosis in Community-ACQUIRED Pneumonia
by: Teng Zhang, et al.
Published: (2022-10-01)

Icariside II Enhances Nrf2 Nuclear Translocation to Upregulate Phase II Detoxifying Enzyme Expression Coupled with the ERK, Akt and JNK Signaling Pathways
by: Meng Chi, et al.
Published: (2011-11-01)

Involvement of AMPKα and MAPK-ERK/-JNK Signals in Docetaxel-Induced Human Tongue Squamous Cell Carcinoma Cell Apoptosis
by: Chin-Chuan Su, et al.
Published: (2022-11-01)

Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
by: Yamei Liu, et al.
Published: (2022-11-01)

Sema3A inactivates the ERK/JNK signalling pathways to alleviate inflammation and oxidative stress in lipopolysaccharide-stimulated rat endothelial cells and lung tissues
by: Qianwen Qiu, et al.
Published: (2023-12-01)

Fucoxanthin Prevents Long-Term Administration <span style="font-variant: small-caps">l</span>-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells
by: Jingwangwei Liu, et al.
Published: (2022-03-01)

Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
by: Yamei Liu, et al.
Published: (2023-02-01)

Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway
by: Ben Ye, et al.
Published: (2022-07-01)

Downregulation of ROR2 attenuates LPS‐induced A549 cell injury through JNK and ERK signaling pathways
by: Zhonglin Wang, et al.
Published: (2023-04-01)

Regulation of Cortico-Thalamic JNK1/2 and ERK1/2 MAPKs and Apoptosis-Related Signaling Pathways in PDYN Gene-Deficient Mice Following Acute and Chronic Mild Stress
by: Fernando Yáñez-Gómez, et al.
Published: (2023-01-01)

Research progress of tumorigenicity-related proteins
by: AO Hui-juan, SHI Jia-chen, WANG Jia-min, Ayimuguli ABUDUREYIMU, QIAO Zi-lin, YANG Kun
Published: (2020-12-01)

The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma
by: Yihong Zhou, et al.
Published: (2017-09-01)

Expressions and Regulatory Effects of P38/ERK/JNK Mapks in the Adipogenic Trans-Differentiation of C2C12 Myoblasts
by: Renli Qi, et al.
Published: (2017-12-01)

Pentoxifylline treatment alleviates kidney ischemia/reperfusion injury: Novel involvement of galectin-3 and ASK-1/JNK & ERK1/2/NF-κB/HMGB-1 trajectories
by: Hagar M. El-Sadek, et al.
Published: (2021-07-01)

Non-esterified Fatty Acid Induce Dairy Cow Hepatocytes Apoptosis via the Mitochondria-Mediated ROS-JNK/ERK Signaling Pathway
by: Yu Li, et al.
Published: (2020-04-01)

Evaluation of serum interleukin-33 and soluble suppression of tumorigenicity 2 (sST2) receptors in patients with and without periodontal disease
by: Himadri Singh, et al.
Published: (2022-01-01)

HO-3867 Induces Apoptosis via the JNK Signaling Pathway in Human Osteosarcoma Cells
by: Peace Wun-Ang Lu, et al.
Published: (2022-06-01)

Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells
by: Fengyu Zhang, et al.
Published: (2020-07-01)

Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK/ERK mediated apoptotic pathways
by: Siya Sun, et al.
Published: (2021-05-01)

Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study
by: Zhiyu Wang, et al.
Published: (2020-01-01)

Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B
by: Fangcheng Zhang, et al.
Published: (2020-04-01)

Improving the Effect of Ferulic Acid on Inflammation and Insulin Resistance by Regulating the JNK/ERK and NF-κB Pathways in TNF-α-Treated 3T3-L1 Adipocytes
by: Jae-Eun Park, et al.
Published: (2024-01-01)

LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway
by: Ying Xing, et al.
Published: (2021-11-01)

The soluble suppression of tumorigenicity 2 as a biomarker of early cardiac remodeling in bradycardia patients receiving permanent pacemaker therapy
by: Mohammad Iqbal, et al.
Published: (2023-01-01)

Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study
by: Ayako Matsumura, et al.
Published: (2020-02-01)

Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells
by: Lianhong Pan, et al.
Published: (2022-07-01)